Immunotherapy is a cancer treatment that harnesses the body's immune system to fight tumors, focusing on the tumor environment and immune mechanisms for innovation.
Urothelial carcinoma and renal cell carcinoma (RCC) are key areas where immunotherapies like immune checkpoint inhibitors (ICIs) have proven effective, with specific agents being used to enhance anti-tumor responses.
Prostate cancer, initially viewed as an "immune cold" tumor, is now increasingly targeted with immunotherapy, especially for specific cases like castration-resistant prostate cancer.